top of page
Reflections on Psychiatry & Psychology


The Resurgence of Psychedelic Psychiatry: An Exciting Yet Cautious Advance
Psychedelic psychiatry is moving from fringe research to mainstream clinical practice. An overview of psilocybin, MDMA, and ketamine — including benefits, risks, and what the evidence supports.
A. Papp MD & Julie Myers, PsyD, MSCP
Jul 7, 20243 min read


Advancing Treatment Approaches for Treatment-Resistant Depression
If multiple antidepressants haven't worked for you, you're not alone and you're not out of options. Why Antidepressants Fail: Lessons from the STAR*D Study Treatment-resistant depression (TRD) is a complex challenge in mental health, characterized by patients' inadequate response to standard antidepressant therapies. The landmark STAR*D study, which extensively evaluated treatment strategies for depression, revealed that a significant percentage of individuals do not respond
A. Papp MD & Julie Myers, PsyD, MSCP
Jun 2, 20242 min read


The "Pipeline"
There are several exciting developments in the field of antidepressants, with various drugs currently in the pipeline. still in various stages of development. Clinical trials are ongoing to evaluate their safety, effectiveness, and potential side effects.
Alexander Papp, MD
Apr 3, 20232 min read
bottom of page